Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders |
| |
Authors: | Ramacciotti Carla E Coli Elisabetta Paoli Riccardo Marazziti Donatella Dell'Osso Liliana |
| |
Institution: | Department of Psychiatry, Pharmacology, Neurobiology and Biotechnologies, Section of Psychiatry, University of Pisa, Italy. c.ramacciotti@ao-pisa.toscana.it |
| |
Abstract: | Most of the evidence from pharmacological studies supports the hypothesis of a serotonergic (5-HT) dysregulation in eating disorders (ED), though a specific alteration related to the major ED subtypes, anorexia (AN) and bulimia nervosa (BN), has not been identified yet, possibly because of changes over time in ED nosology. The aim of the present study was to verify whether differences in serotonergic activity, measured by platelet 3H]paroxetine binding, would validate current ED classification. Platelet 3H]paroxetine binding was investigated in 26 patients with eating disorders diagnosed in accord with DSM-IV criteria (AN, n=11; BN, n=15) and 26 normal weight controls of comparable age; ED symptomatology was assessed by the Diagnostic Schedule for Eating Disorders. ED patients had significantly lower B(max) values than controls (288.5+/-109.2 vs. 1396.8+/-251.3 fmol/mg), whereas the K(d) was not significantly altered (0.12+/-0.13 and 0.12+/-0.05 nM, respectively). Among patients, differences in B(max) were related neither to DSM-IV subtypes nor to clinical variables such as presence of binge-eating, purging, impulsive behaviors, or symptoms of depression. Although ED patients share a dysregulation in serotonergic activity, DSM-IV subtype classification was not validated by 3H]paroxetine binding, and hence does not correspond to a specific 5-HT profile. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|